JPM vs LKFN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
LKFN presents a dichotomy between strong fundamental growth and concerning internal sentiment. The company maintains a stable health profile with a Piotroski F-Score of 4/9 and exhibits impressive earnings growth of 23.4% YoY. While the current price of $60.88 sits comfortably between the Graham Number ($52.23) and the growth-based Intrinsic Value ($118.29), the outlook is dampened by a bearish technical trend and significant insider selling by the CEO and CFO. Consequently, the stock is a fundamental hold with a valuation that is fair but lacks a near-term catalyst.
Compare Another Pair
Related Comparisons
JPM vs LKFN: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Lakeland Financial Corporation (LKFN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.